During a conversation with ICMR DG, the state Health Minister was informed that the vaccines trial will begin by July 7 in 13-14 hospitals
Rajesh Tope
Maharashtra Health Minister Rajesh Tope is hopeful and positive about the indigenous COVID-19 vaccine after the Indian Council of Medical Research (ICMR) DG Balram Bhargava informed that the vaccine trial will begin by July 7 on Friday. During a conversation with ICMR DG, the state Health Minister was informed that the vaccine's trial will begin by July 7 in 13-14 hospitals. Pre-clinical and clinical trials are expected to be completed by August 15, read the press note from the Health Minister's office. Bharat Biotech had recently received a nod for a clinical trial of its vaccine - Covaxin.
The Indian Council of Medical Research (ICMR) DG Balram Bhargava has written a letter to Bharat Biotech and principal investigators of medical colleges to complete the trial procedure of indigenous COVID-19 vaccine in a fast track method, so that results of a clinical trial can be launched by August 15.
"This is the first indigenous vaccine being developed by India and is one of the top priority projects which is being monitored at the topmost level of the Government. The vaccine is derived from a strain of SARS-CoV-2 isolated by the ICMR-National Institute of virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine," the letter read.
A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government.
India reported the highest ever single-day spike of 20,903 COVID-19 cases in the last 24 hours. The country's coronavirus case count has risen to 6,25,544.
Catch up on all the latest Mumbai news, crime news, current affairs, and a complete guide from food to things to do and events across Mumbai. Also download the new mid-day Android and iOS apps to get latest updates.
ADVERTISEMENT
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
